Defence Therapeutics Inc.
OTC: DTCFF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sébastien Plouffe
- Employees
- 1,300
- Headquarters
- Vancouver, Canada
- IPO year
- 2021
- Market cap
- $21.3M
- Website
- http://www.defencetherapeutics.com
Loading DTCFF…
Loading profile data…Frequently asked questions about DTCFF
What does Defence Therapeutics Inc. (DTCFF) do?
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on the research, development, and advancement of products using its Accum technology...
Where does DTCFF trade?
Defence Therapeutics Inc. (DTCFF) trades on the Other OTC.
What sector is DTCFF in?
Defence Therapeutics Inc. (DTCFF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Defence Therapeutics Inc.?
Sébastien Plouffe is the chief executive officer of Defence Therapeutics Inc. (DTCFF).
Where is Defence Therapeutics Inc. headquartered?
Defence Therapeutics Inc. is headquartered in Canada.
Does DTCFF pay a dividend?
Defence Therapeutics Inc. (DTCFF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DTCFF go public?
Defence Therapeutics Inc. (DTCFF) completed its initial public offering in 2021.